<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04112576</url>
  </required_header>
  <id_info>
    <org_study_id>C2116</org_study_id>
    <nct_id>NCT04112576</nct_id>
  </id_info>
  <brief_title>Physiological Signals, Activity and Posture for Surface Mounted Insertable Cardiac Monitor in Heart Failure Study</brief_title>
  <acronym>HAPI-HF</acronym>
  <official_title>Physiological Signals, Activity and Posture for Surface Mounted Insertable Cardiac Monitor in Heart Failure Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To characterize the physiological signals collected from a Wearable Cardiac Monitor (WCM)&#xD;
      prototype device in subjects with heart failure and preserved ejection fraction (HFpEF) and&#xD;
      compare against signals from subjects with heart failure and reduced ejection fraction&#xD;
      (HFrEF).&#xD;
&#xD;
      To evaluate the relationship of physiological signals measured from a wearable cardiac&#xD;
      monitor (WCM) prototype device with ECHO measures of systolic and diastolic function&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-randomized, feasibility study that will enroll up to 100 participants&#xD;
      clinically diagnosed with HFpEF or HFrEF. Approximately 70% of participants will have HFpEF&#xD;
      and 30% will have HFrEF.&#xD;
&#xD;
      There will be one study visit per participant. The study visit includes device placement and&#xD;
      data collection during postural changes. Echocardiograms will also be collected throughout&#xD;
      the study and at least 30% of participants will undergo a submaximal exercise test. The&#xD;
      device will then be removed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Physiologic Signal Detection</measure>
    <time_frame>12 months</time_frame>
    <description>Characterize differences in cardiac physiology and dynamics between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction patient populations using a wearable cardiac monitor prototype device.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <condition>Heart Failure, Diastolic</condition>
  <arm_group>
    <arm_group_label>HFrEF</arm_group_label>
    <description>Participants that are diagnosed with NYHA class II or III heart failure with reduced ejection fraction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFpEF</arm_group_label>
    <description>Participants that are diagnosed with NYHA class II or III heart failure with preserved ejection fraction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wearable cardiac monitor</intervention_name>
    <description>Participants will be fitted with a wearable cardiac monitor placed on the skin that measures physiologic signals.</description>
    <arm_group_label>HFpEF</arm_group_label>
    <arm_group_label>HFrEF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that are diagnosed with NYHA class II or III heart failure with preserved or&#xD;
        reduced ejection fraction.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with NYHA class II or III heart failure defined by symptoms and signs of&#xD;
             heart failure&#xD;
&#xD;
          -  Documented episode of decompensated heart failure in the past 3 years, which either:&#xD;
             a) resulted in a hospital admission (primary diagnosis) or b) was treated in&#xD;
             out-patient clinic&#xD;
&#xD;
          -  HFrEF defined by documented evidence of EF ≤ 40% OR&#xD;
&#xD;
          -  HFpEF defined by documented evidence of:&#xD;
&#xD;
          -  EF ≥ 50% and no prior record of EF &lt; 40%&#xD;
&#xD;
          -  Evidence of relevant structural heart disease or diastolic dysfunction on&#xD;
             echocardiographic as defined in the 2016 ESC guidelines&#xD;
&#xD;
          -  Able to understand and willing to provide written informed consent to participate in&#xD;
             the trial&#xD;
&#xD;
          -  Age 21 years old or greater&#xD;
&#xD;
          -  Willing and able to participate in the required testing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior hospitalization, CV event or surgery within 6 weeks&#xD;
&#xD;
          -  Subject is currently enrolled in another clinical trial (excluding registries) that&#xD;
             may interfere with the placement of the study system or include the usage of&#xD;
             investigational drugs.&#xD;
&#xD;
          -  Patients with Active Implantable Medical Devices&#xD;
&#xD;
          -  Known allergy to materials used in the study (adhesive tape, titanium, ECG electrodes)&#xD;
&#xD;
          -  Have a prosthetic cardiac valve, previously underwent cardiac valve surgery or have&#xD;
             hemodynamically unstable (as judged by local investigator) valvular disease&#xD;
&#xD;
          -  Subject is pregnant as indicated by patient record&#xD;
&#xD;
          -  Patients with rash or open wound on torso locations where investigational devices will&#xD;
             be placed&#xD;
&#xD;
          -  Patient deemed as clinically unstable or unsuitable to perform prescribed testing as&#xD;
             judged by the local investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolyn Lam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart Center Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashley M Jensen, MS</last_name>
    <phone>651.582.4908</phone>
    <email>ashley.jensen@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephen J Hahn, PhD</last_name>
    <phone>651.582.4521</phone>
    <email>stephen.hahn@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjiv Shah, MD</last_name>
      <phone>312-695-0063</phone>
      <email>sanjiv.shah@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Heart Center Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169609</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Sim, MD</last_name>
      <phone>65.6704.8965</phone>
      <email>david.sim@singhealth.com.sg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MacKay Memorial Hospital</name>
      <address>
        <city>Taipei City</city>
        <zip>10449</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chung-Lieh Hung, MD</last_name>
      <phone>866.975.836.018</phone>
      <email>jotaro3791@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>echocardiogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

